Motivation, optimism and self-concept in sports

Tres constructos psicológicos como son autoconcepto físico, optimismo y motivación podrían estar más relacionados en el ámbito del deporte de lo que parece a priori. El objeto de este estudio es analizar cómo se relacionan estas variables. Se espera que se revelen algunas correlaciones positivas entre los distintos constructos y su relación con ambos géneros. Para ver la relación entre las tres variables se contó con una muestra de 113 participantes (51 mujeres y 62 hombres), de edades comprendidas entre 18 y 60 años. Los resultados obtenidos mostraron la relación entre autoconcepto físico y optimismo, y optimismo y motivación sin diferencias entre hombres y mujeres. Sin embargo también se ha encontrado una relación negativa entre autoconcepto y motivación, contraria a lo que cabría esperar. Tres constructos psicológicos como son autoconcepto físico, optimismo y motivación podrían estar más relacionados en el ámbito del deporte de lo que parece a priori.Three psychological constructs such as the physical self, optimism and motivation may be more related to the field of sport than it seems a priori. The purpose of this study is to analyze how these variables are related. It is expected that some positive correlations between constructs and their relationship with both genders are revealed. To see the relationship between the three variables had a sample of 113 participants (51 women and 62 men), aged between 18 and 60. The results showed the relationship between physical self and optimism, and optimism and motivation no difference between men and women. However it has also found a negative relationship between self -concept and motivation, contrary to what one would expect.ReiDoCrea. Departamento de Psicología Social. Universidad de Granada

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results

Persistence of Anti-SARS-CoV-2 Antibodies Six Months after Infection in an Outbreak with Five Hundred COVID-19 Cases in Borriana (Spain): A Prospective Cohort Study

In March 2020, several mass gathering events were related to the Falles festival in Borriana (Spain), resulting in a 536 laboratory-confirmed COVID-19 cases outbreak among participants. This article estimates anti-SARS-CoV-2 antibodies persistence six months after and factors associated with antibody response. A prospective population-based cohort study was carried out by the Public Health Centre of Castellon and the Emergency and Clinical Analysis and Microbiology Services of Hospital de la Plana in Vila-real. In October 2020, a seroepidemiologic study was used to estimate the persistence of anti-SARS-CoV-2 antibodies against nucleocapsid protein (N) by an electrochemiluminescence immunoassay (ECLIA) was implemented. We enrolled 484 (90.2%) of the 536 members of the initial outbreak cohort and detected persistent antibodies in 479 (99%) without reinfection episodes. Five participants had a negative antibody test. Factors associated with a negative result were a lower body mass index (BMI), and less contact with other COVID-19 cases. Among the 469 participants with two ECLIA tests, 96 (20.5%) had an increase of antibodies and 373 (79.5%) a decline. Increased antibodies were associated with older age, higher BMI, more severe illness, and low current smokers. Our results show that after a COVID-19 infection, a high proportion of cases maintain detectable anti-SARS-CoV-2 antibodies